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Although smoking cessation is clearly beneficial, many smokers respond poorly to smoking ces-
sation efforts with rather disappointing overall success rate of long-term abstinence. The per-
ceived lack of effectiveness of smoking cessation may well influence how physicians set their
priorities with regard to an effective use of their consultation time. Negative beliefs and atti-
tudes can be resolved by advancing the general understanding of the natural history of quit-
ting, by making sensible use of smoking cessation services, and by being aware of the
correct use of drugs for nicotine dependence when prescribed. In particular, a better under-
standing of predictors of success in smoking cessation can help physicians in id entifying
smokers who stand a fair chance of quitting. The purpose of the present article is to review
those predictors of smoking cessation that can be of help in routine clinical consultation.
ª 2008 Elsevier Ltd. All rights reserved.Introduction
Cigarette smoking is a modern day epidemic that poses
substantial health burden and costs.1
The long-term risks of smoking have been definitely
quantified in a 50-year prospective cohort study of over
34,000 male British doctors that compared the overall
survival of smokers a nd non-smokers over time showing
remarkable difference in mortality rates between smokers
and non-smokers.2 The American Cancer Society’s second
Cancer Prevention Study involving more than one million095 7435440; fax: þ39 095
(P. Caponnetto).
8 Elsevier Ltd. All rights reservedadults found that, among males in the USA, smoking is asso-
ciated with about two-thirds of all the deaths in middle age
among those who smoke cigarettes regularly with a strong
doseeresponse relationship.3 Peto et al.4 have recently
estimated mortality from smoking in the European Union
(EU). On average, smokers who die as a result of their smok-
ing die 14 years earlier than never-smokers.
There is now abundant evidence that health risks
associated with cigarette smoke can be reversed following
a sufficient period of abstinence, and achieving life-long
abstinence is an important public health goal for both
developed and developing countries.5,6 Smoking cessation
is an important component of tobacco-control policies
and evidence-based recommendations indicate that it is
beneficial to smokers. Typically, the spectrum of available
smoking cessation interventions spans from simple advice.
Common predictors of smoking cessation 1183to intensive behavioural support together with pharmaco-
logical treatment.7
The perceived lack of effectiveness of smoking cessation
may well influence how physicians set their priorities with
regard to an effective use of their consultation time. A
recent systematic review has revealed that approximately
40% of primary care physicians felt that advising smokers
about cessation is time-consuming and ineffective.8 Physi-
cians’ negative beliefs and attitudes can be resolved by
emphasizing that valuable predictors of smoking cessation
can be easily identified thus making an efficient use of their
time.
Hence, identification of individual characteristics that
predict success in smoking cessation efforts is highly desir-
able as this could help to match smokers with a strategy
that is more likely to help them quit, to identify smokers
who might need more intensive treatment (who would then
require referral to specialist centres), and to make the
most of health care resources.
In this review article, we describe predictors of smoking
cessation that can be of help in routine clinical consultation.
These predictors have been identified on the basis of
a literature search in PubMed. The terms for the search
were ‘‘smoking cessation’’ and ‘‘predictor*’’.We limited our
search to Titles and Abstracts of human studies published in
English. The initial search resulted in 439 hits. Data on long-
term (6 months) quit rates must have been presented in
studies of adequate sample size for inclusion. Smoking cessa-
tion studies on specific population groups (e.g., chronic dis-
ease populations, psychiatric disorders, special ethnic
groups, adolescents) were not considered for inclusion. We
identified 202 relevant articles addressing predictors of
smoking cessation including reviews and meta-analyses.
The search repeatedly identified a number of predictors
including: sex, age, age at smoking initiation, history of pre-
vious quit attempts, depression, anxiety, nicotine depen-
dence, alcoholism, motivation, living as a couple, and
presence of smokers in the household and in the workplace.
This article is organized by illustrating each predictor focus-
ing on seminal work and critical studies to elucidate key out-
comes. Suggestions will be generated in order to help with
decision-making in the context of a busy clinic, to maximize
physicians’ consultation time, and to improve smoking ces-
sation outcomes in primary care.Barrier to smoking cessation
The large majority of smokers around the world desire to
quit for good; but this is not easy. In the United States more
than 70% of adult cigarette smokers had made at least one
attempt to quit during their smoking careers, and approx-
imately 41% of them had tried to quit in the previous 12
months.9 Nevertheless, only about 7% of self-quitters were
sti ll abstinent 1 year later.7 Such low quit rates have at-
tracted interest in the area of professional and behavioural
counselling and stimulated investment in the development
of pharmacological aids for smoking cessation. Evidence
shows that brief advice from a medical professional and
behavioural support are effective in motivating smokers
to quit and that more intensive interventions are more ef-
fective than minimal interventions.10e12 Moreover, addingdrugs for smoking cessation (including NRT and non-nicotine
treatments) to these interventions can approximately dou-
ble the rate of abstinence in motivated smokers.13,14 De-
tails about pharmacological and non-pharmacological
smoking cessation interventions will not be covered here,
and it is recommended to refer to previous excellent
review articles on this specific subject.7,15,16
Despite the development of several cessation strategies,
the overall success rate of long-term smoking abstinence is
modest, even when intensive interventions are implemen-
ted.13e16 This underscores the notion that smoking cessa-
tion requires a substantial change in lifestyle and for
most smokers this remains a high-effort task. It usually re-
quires multiple quit attempts as well as persistence in exe-
cuting cognitive and behavioural coping skills and resisting
smoking in the face of aversive withdrawal symptoms, neg-
ative affect, and powerful urges or cravings. Besides psy-
chological factors, quitting is also likely to involve
pharmacological factors and both may be under the influ-
ence of specific genetic polymorphisms.17,18
Predictors of smoking cessation
The notion that many smokers respond poorly to smoking
cessation efforts has fuelled the physicians’ negative
attitudes towards smoking cessation and it is likely to
influence their priorities with regard to an efficient use of
their consultation time.8 One way of addressing these phy-
sicians’ negative beliefs and attitudes is by emphasizing
that valuable predictors of smoking cessation can be easily
identified. Several factors are known to indicate whether
a smoker is more or less likely to quit and their acquain-
tance can be translated into an efficient use of physicians’
consultation time. Our search has identified a number of
common predictors that can be grouped into the following
domains: personaledemographic and social/familial con-
text (e.g., sex, age, age at smoking initiation, previous
quit attempts, living as a couple, smokers in the household
and in the workplace), psycho(patho)logical/physio(patho)-
logical, (e.g., depression, anxiety, nicotine dependence,
alcoholism), and cognitive (e.g., motivation) (Table 1).
Gender-specific predictors
Many studies have suggested that men have a better long-
term outcome than women. Although women smoke fewer
cigarettes and attempt to quit smoking at the same rate as
men,7 they appear to be less likely to succeed at quitting
smoking than men, whether trying to quit on their own or
using some type of cessation assistance (nicotine replace-
ment therapy - NRT or bupropion).19e21 The observation
of lower quit rates for women receiving NRT is often cited
as evidence for the hypothesis that women may be less
likely to obtain therapeutic benefit from NRT.22
That women have usually a worse long-term outcome
than men has been generally attributed to womens greater
concerns about weight gain as a precipitant for relapse. As
a matter of fact, cigarette smoking for many women is an
effective aid used to control weight.23 Furthermore,
women appear to be less motivated to quit smoking.24,25
Probably, this o ccurs because women are more likely to
Table 1 Common predictors of smoking cessation
Domain Factor Practical suggestions Odds ratios
Personal/socio-
demographic
Female gender Although several s tudies have suggested that men have a better
long-term outcome than women, it is interesting to note that
in real-world situations there is no gender difference in
effectiveness of smoking cessation treatment.
NRT was effective at all time points in men (<6 months:
ORZ 2.05, 95% CIZ 1.61e2.60; 6 months: ORZ 1.98, 95%
CIZ 1.51e2.60; 12 months: ORZ 1.86, 95% CIZ 1.39e
2.50) and women (<6 months: ORZ 2.09, 95% CIZ 1.65e
2.65; 6 months, ORZ 1.52, 95% CIZ 1.17e1.98; 12
months: ORZ 1.63, 95% CIZ 1.22e2.18). At all time
points, no significant difference was observed between
sexes (<6 months: ORZ 0.97, 95% CIZ 0.69e1.36; 6
months: ORZ 1.33, 95% CIZ 0.91e1.95; 12 months:
ORZ 1.21, 95% CIZ 0.79e1.84).
Special considerations often must be given when assisting women to
quit smoking. These include addressing bodyweight gain concerns, the
question of medication use in pregnant smokers, influences on mood
and withdrawal, the impact of social support, and the possibility of
greater sensitivity of women to environmental cues associated with
smoking. Some medications can help attenuate bodyweight gain, at
least temporarily, and even responsiveness to cues. Greater focus
on developing improved counselling interventions for these and
other issues surrounding cessation could substantially enhance quit
rates in women.33
Age at smoking
initiation
Early smoking initiation points to significant nicotine dependency and
high risk of relapse37e39; it is advised to institute an aggressive
smoking cessation strategy from the beginning.
Men who started smoking before 16 years of age had
an OR of 2.1 (95% confidence interval: 1.4e3.0) for not
quitting smoking compared to those who started at a
later age.
Previous quit
attempts
A positive history of previous quit attempts should be exploited to
boost motivation, because if a smoker managed to quit in the past
it is more likely that he/she will be successful in a future smoking
cessation attempt. In particular, given that the longer a smoker
remained abstinent (>5 days),the more he or she is likely to succeed
on a subsequent attempt, the physician might reinforce any effort
to extend abstinence, at least as practice for the next attempt.
Also it is important to elicit what led to previous relapses, in order to
identify ways to prevent future relapse.44e46
Among men, the longest previous quit attempt
(ORZ 1.09, 95% CIZ 0.68e1.02) was positively related to
success at 1 year. Among women, the longest previous
quit attempt (ORZ 1.23, 95% CIZ 1.11e1.39) was
associated with ce ssation at 1 year.
Being married
(living as
a couple) and/or
not having any
other smokers
in the household.
It is important to take advantage of socialefamilial support as part of an
existing smoking cessation program.7,116,121
Not having any other smokers in the household is a
strong predictor of success with an OR of 1.43, 95%
CIZ 1.25e1.65
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Psychological
and
physiological
Depression During consultation it is advised to ascertain systematically whether a
history of depression is present. Smokers in this category are likely to
experience intense withdrawal symptoms and will benefit from intensive
pharmacological t reatment for smoking cessation during the first 2e3
weeks of abstinence. Moreover, a judicious use of antidepressants should
be considered and a referral to a specialist for the most challenging cases
is advised.58e60
Particip ts treated with antidepressants had a positive
associa between degree of depression and likelihood
of abst ce (ORZ 1.35 [CIZ 1.00e1.81]); for controls,
the opp te was true, and increasing depression scores
were a iated with decreasing likelihood of abstinence.
Smoker ith recurrent major depressive disorder and
heavy s kers who were treated for depression were
signific ly more likely to be abstinent than those
receivi tandard cognitive behavioural therapy
(ORZ [CI Z 1.05e5.03] and
2.62 [C 1.18e5.83]).
Anxiety During consultation it is advised to ascertain the level of anxiety by using
simple validated questionnaires such as the Hamilton Anxiety Scale
(HAM-A).72 Be aware that anxiety is one of the nicotine withdrawal
symptoms and smokers should be advised that their level of anxiety may
increase within the first couple of weeks after smoking cessation. Smokers
in this category will benefit from pharmacological treatment for smoking
cessation during the first 2e3 weeks of abstinence. Moreover, a judicious
use of anxiolytic drugs may be considered in individual cases.73
Compa with non-nicotine-dependent smokers or
non-sm rs, those with nicotine dep endence have
a great isk for having one or more anxiety disorders
(ORZ for males and 2.6 for females)
High level of
nicotine
dependence
In general, smokers with a FTND 7 are likely to experience intense
withdrawal symptoms and may be expected to relapse early. Smokers in
this category could benefit from more intensive pharmacological
treatment for smoking cessation during the first weeks of abstinence.74,76
Charac stics that reduced the odds of quitting
include wo indicators of nicotine dependence
(smokin ithin 30 min of waking and higher cotinine
levels). oking within 30 min of waking (ORZ 0.40;
95% CI .25e0.62) and highe r salivary cotinine
levels a aseline (ORZ 0.799; 95% CIZ 0.629e0.922).
Alcohol use
and abuse
All smokers should be advised to quit by their physician, but if a history
of current alcoholism is present, a referral to a specialist centre may be
recommended, because smokers in this category have been shown to
perform poorly in smoking cessation programs.86,87,89 However, a smoker
with a mild alcohol problem, probably would not need to be referred to
a specialist. In addition, the notion that even low to moderate levels of
alcohol consumption during smoking cessation may decrease treatment
success calls for a sensible plan against alcohol use during smoking
cessation efforts.
Efficac nicotine replacement or bupropion for
smokin ssation in smoke rs with past alcohol
problem s. smokers with no alcohol problems.
NRT vs acebo OR in smokers with no problems 2.7
(1.5e4 OR in smokers with past problems 4.1
(0.2e9 . Bupropion vs. Placebo OR in smokers
with no oblems 1.7 (1.1e2.5); OR in smokers with
past pr ems 1.9 (0.4e8.6).
Cognitive Low motivation
to stop smoking
Motivational interviewing may be required.102,104 For those not interested
in quitting, it is important that some motivational counselling occur during
the medical visit, which is a window of opportunity. Alternatively,
physicians should be encouraged to use their regular contacts with smokers
to gradually increase their level of motivation towards a quit attempt with
the ‘‘5 R’s’’: Relevance, Risks, Rewards, Ro adblocks, and Repetition.107
None re rted
C
o
m
m
o
n
p
re
d
icto
rs
o
f
sm
o
kin
g
ce
ssa
tio
n
1185an
tion
inen
osi
ssoc
s w
mo
ant
ng s
2.3
IZ
red
oke
er r
2.2
teri
d t
g w
Sm
Z 0
t b
y of
g ce
s v
. Pl
.6);
2.7)
pr
obl
po
1186 P. Caponnetto, R. Polosaanticipate negative outcomes associated with smoking ces-
sation (such as weight gain, increases in negative mood, re-
duced ability to concentrate, and loss of enjoyment)
compared to men.21 As a final point, women have higher
rates of depression than men and are more likely to use
smoking as a means of handling negative affects.26 Negative
mood (including depression, anxiety, irritability, and
impaired concentration) is generally associated with failure
to quit in women.27e29
Contrary to the notion that women may be less likely to
quit, two separate meta-analyses have found NRT and
bupropion equally effective in men and women.30,31 Rand-
omised controlled trial s included in these meta-analyses
may not reflect risk factors for failure in real-life setting,
However, it is interesting to note that in real-world situa-
tions there is no gender difference in effectiveness of
smoking cessation treatment.32
Special attention must be given when assisting women
quitting smoking. These include addressing bodyweight gain
concerns, the question of medication use in pregnant
smokers, the influence of social support, and the possibility
of greater sensitivity of women to environmental cues
associated with smoking. Some medications can help
attenuate bodyweight gain, at least temporarily, and
even responsiveness to cues. Targeted counselling inter-
ventions for these and other issues surrounding cessation
could enhance quit rates in women,33 but there is a need to
understand more about the role of gender influences.
Age at smoking initiation
Early initiation of cigarette smoking has been associated
with greater consumption, longer duration of smoking, and
increased nicotine dependence.34,35 Taioli andWynder35 ob-
served that those who began smoking before age 14 were
more likely to become heavy smokers than those who began
when they were 20 years of age or older. That age at initia-
tion of smoking is a significant factor for continuation of
smoking later in life, has been convincingly demonstrated
by the work of Hymowitz et al.,36 which analysed smoking
cessation data from a prospective cohort of 13,415 cigarette
smokers; statistically significant predictors of smoking ces-
sation included initiation of smoking after age 20. In an ex-
tension of their previous work, Breslau et al.37 investigated
the relationship between smoking cessation and age of initi-
ation and found that in a sample of 1007 randomly selected
young adults the likelihood of cessation was significantly
lower in smokers who initiated smoking before age 13. Simi-
lar findings were observed by Khuder et al.38; those who
started smoking before 16 years of age had an odds ratio of
2.1 for not quitting smoking compared to those who started
at a later age. The same authors observed that, in addition,
early age at initiation may also affect the length of absti-
nence time; those who started smoking before age 16 had
a mean of 6.7 years of abstinence from smoking, in compar-
ison to 11 years for those who started at a later age. It is pos-
tulated that early exposure to tobacco could detrimenta lly
affect a developing brain thus leading to greater nicotine de-
pendence later in life. In addition, age at smoking initiation
appears to be significantly related to smoking cessation,with
smoking initiation at early age appearing to be a critical
factor influencing smoking cessation. That early age ofinitiation predicts more dependent smoking was also
reported in a sample of 2120 adult smokers in 24 worksites
in the US.39
When a history of early smoking initiation is obtained, it
is advised to institute an aggressive smoking cessation
strategy from the beginning. Physicians should be aware
that smokers in this category are at high risk of relapse and
need to understand that successful cessation will require
multiple attempts.
Previous quit attempts
A history o f previous quit attempts is an important
indicator for the success of future quitting in both adult
and adolescent smokers.40e44 Both number and duration of
previous unassisted quit attempts are important predictors
of subsequent long-term cessation. However, those who
have made any quit attempts that lasted longer than 5
days are much more likely to succeed than those who
have not sustained a quit for that long. Specifically, in
women who smoke45 the length of previous quit attempt
significantly predicted quitting vs. smoking or dropout,
over and above all other variables. Women with longer pre-
vious quit attempts were 36% more likely to quit than to
continue smoking or drop out. Conversely, reported shorter
periods of abstinence on p rior quit attempts were mark-
edly associated to relapse.46
A positive history of previous quit attempts should be
exploited to boost motivation, because if a smoker man-
aged to quit in the past it is more likely that he/she will be
successful in a future smoking cessation attempt. In
particular, given that the longer a smoker remained
abstinent (>5 days), the more he or she is likely to succeed
on a subsequent attempt, the physician might reinforce any
effort to extend abstinence, at least as practice for the
next attempt. Also it is important to elicit what led to
previous relapses, in order to identify ways to prevent
future relapse.44e46
Depression
The association between nicotine dependence and affec-
tive disorders, particularly major depressive disorder
(MDD), is well known with high prevalence rates being
reported for smokers.47,48 The reason for this association is
not clear, but it has been argued that smoking may help in-
dividuals to cope with stress49 or medicate depressed
mood.50 In support of this hypothesis, it has been shown
that smokers with a history of depression who abstain
from smoking are at significantly increased risk of develop-
ing a new episode of major depression and this risk remains
high for at least 6 months.51,52 On the other hand, there is
evidence that current cigarette use could be an important
determinant of developing depressive symptoms in adoles-
cence.53 Moreover, it cannot be excluded that a shared
vulnerability could be playing a role.54 Whatever the mech-
anisms of this association, it is likely that the burden of af-
fective disorders will increase with the current escalation
of smokers worldwide.55
Until recent years, the belief that a history of depression
greatly decreases the likelihood of quitting smoking has
Common predictors of smoking cessation 1187been widely promoted.56 It must be noted that the process
of cessation itself produces withdrawal symptoms, which
include a variety of mood disturbances and affective symp-
toms (depressed mood, anxiety, nervousness, restlessness,
irritability, fatigue, and drowsiness); these are more pro-
nounced in the days immediately following cessati on and
generally return to baseline levels within a month of contin-
ued abstinence. These differences in mood disturbance
appear to be related to successful cessation as well.
Predictably, smokers reporting higher levels of negative
mood and depressive symptoms were less likely to quit
than were smokers with less mood disturbance.48
Although it is generally assumed that a history of de-
pression may be a barrier to quitting smoking, contradictory
evidence also exists.57,58 The meta-analysis by Hitsman
et al.57 shows that lifetime history of major depression
does not appear to be an independent risk factor for cessa-
tion failure in smoking cessation treatment. Likewise, a re-
cent paper from the Veterans Administration Normative
Aging Study shows that the presence of depressive s ymptoms
did not have a significant impact on smoking cessation.58
During consultation it is advised to ascertain systemat-
ically whether a history of depression is present by using
simple validated questionnaires such as the Beck Depres-
sion Inventory (BDI).59 Smokers in this category are likely to
experience intense withdrawal symptoms and will benefit
from intensive pharmacological treatment for smoking ces-
sation during the first 2e3 weeks of abstinence. Moreover,
a judicious use of antidepressants should be considered
and a referral to a specialist for the most challenging cases
is advised.60e62
Anxiety
Smoking is highly prevalent across most anxiety disorders
and varies widely, depending on the specific diagnosis and
the sample selected.63 The highest prevalence estimates of
smoking have been found among those with panic disorder
with or without agoraphobia63,64 and among those with
post-traumatic stress disorder.65,66 A high prevalence of
smoking has also been identified among individuals with so-
cial anxiety disorder, generalized anxiety disorder, and spe-
cific phobias.63,64,67
Smokers with anxiety disorders have more severe with-
drawal symptoms during smoking cessation than smokers
without anxiety disorders.68 Moreover, smokers commonly
implicate anxiety as a risk factor for relapse to smok-
ing.63,69 In these cases, psychological treatments that in-
corporate cognitive restructuring of automatic thoughts
may also have considerable utility.63
Understanding the functional relationship between
smoking behaviour and anxiety is important to improve
assistance to those who are trying to quit, but additional
research is also needed to understand factors contributing
to the development, maintenance, and relapse to smoking
that are important to smokers with anxiety disorders.
Although no treatment outcome studies have been
published to date regarding smoking cessation and anxiety
disorders specifically, a natural extension for smoking
cessation treatment in patients with anxiety disorders can
be made from the panic disorder and benzodiazepine
withdrawal treatment literature. Several studies havedocumented the benefit of simultaneously tapering benzo-
diazepines during cognitiveebehavioural therapy for panic
disorder.70,71
During consultation it is advised to ascertain the level of
anxiety by using simple validated questionnaires such as the
Hamilton Anxiety Scale (HAM-A).72 Be aware that anxiety is
one of the nicotine withdrawal symptoms and smokers
should be advised that their level of anxiety may increase
within the first couple of weeks after smoking cessation.
Smokers in this category will benefit from pharmacological
treatment for smoking cessation during the first 2e3 weeks
of abstinence. Moreover, a judiciou s use of anxiolytic drugs
may be considered in individual cases.73
Nicotine dependence
Severity of nicotine dependence has been described to be an
important predictor of successful smoking cessation, both in
the context of studies with bupropion74,75 in trials with nic-
otine replacement therapy76 and in studies of cessation
without adjuvant pharmacotherapy.77,78 Severity of nicotine
dependence is generally assessed by means of the Fager-
stro¨m Test for Nicotine Dependence (FTND),79 a straightfor-
ward 6-item questionnaire that tak es less than one minute
to be administered. Results are expressed as scores ranging
from 0 to 10, the highest score indicating a very high level of
nicotine dependence. Typically, smokers with severe nico-
tine dependence are characterized by a FTND 7.79 Such
nicotine dependence measures also appear to identify those
smokers requiring high-dose nicotine pharmacotherapy.80,81
There are nonetheless a number of studies that have failed
to confirm the predictive validity of these widely used
dependence measures.82e84 However, the supportive evi-
dence is reasonably strong and dependence measures are
generally recommended as a key indicator for nicotine
depe ndence or as an important predictor of cessation
success.10,85
In general, smokers with a FTND 7 are likely to experi-
ence intense withdrawal symptoms and may be expected to
relapse early. Smokers in this category could benefit from
more intensive pharmacological treatment for smoking
cessation during the first weeks of abstinence.74,76 Success-
ful cessation may require multiple attempts.
Alcoholism
Current alcoholism is a negative prognostic factor for
successful smoking cessation and discontinuation of alco-
holism is likely to increase the potential for successful smok
ing cessation. After correcting for sex, age and race,
population studies have shown that smokers with active
alcoholism in the preceding year were 60% less likely to quit
than were smokers with no history of alcoholism.86 It was
also interesting to observe that smokers whose alcoholism
had remitted were at least as likely to quit as smokers re-
porting no alcohol use, with a greater than threefold in-
crease in the likelihood of subsequent smoking cessation
compared with smokers with current alcohol use. The notion
that current alcoholism may interfere with the success of
smoking cessation was confirmed in subsequent studies
of smokers attending smoking cessation clinics, which
1188 P. Caponnetto, R. Polosapredicted smoking relapse not only for smokers with current
alcoholism at baseline but also for any alcohol use during
cessation treatment.87 Conversely, it appea rs that smoking
cessation did not precipitate an alcoholic relapse88 and in ac-
tual fact smoking cessation programs appear to improve quit
rates in abusers undergoing alcohol treatment.89e91 Al-
though the reasons for the detrimental effect of alcoholism
on smoking cessation are unclear, controlled studies have
shown that alcohol has the ability of producing a generalized
increase in reported urge to smoke.92,93
There is currently increasing support for addressing
smoking cessation in alcohol dependent persons, but the
most efficacious strategies for smoking cessation in this
population are not clear.94 Behavioural therapy strategies
are clearly important in smoking cessation programs for
the gene ral population, but it appears that low-intensity
programs are not effective in patients in alcohol treat-
ment.95 Behavioural therapy for smoking cessation that
are similar to standard counselling approaches for alcohol
dependence has been shown to be very effective in recov-
ering alcoholics with quit rates at 1 year that are compara-
ble to persons without an alcohol addiction history at
approximately 25%.96
All smokers should be advised to quit by their physician,
but if a history of current alcoholism is present, a referral
to a specialist centre may be recommended, because
smokers in this category have been shown to perform
poorly in smoking cessation programs.86,87 However,
a smoker with a mild alcohol problem, probably would
not need to be referred to a specialist. In ad dition, the no-
tion that even low to moderate levels of alcohol consump-
tion during smoking cessation may decrease treatment
success calls for a sensible plan against alcohol use during
smoking cessation efforts.
Motivation
Individual motivation to stop smoking appears to be
important in predicting whether a given cessation attempt
will be successful.97,98 Accumulating evidence indicates
that initial levels of motivation to quit smoking can predict
success with smoking cessation.99e101 Tests to assess the
level of motivation are available, but these are cumber-
some, time-consuming or poorly validated. However, physi-
cians can ask smokers to rate their level of motivation or
confidence on a scale of 0e10; this can be quite useful
and it takes about 30 sec.102
As the effect of motivation on outcome appears to wane
with time (usually in a few weeks),103 it is imperative that
physicians take full advantage of the smoker’s momentum
and set a quit date as soon as possible. The medical visit
is a time in which health is salient, and smokers may be
more receptive to attempts aimed at increasing their level
of motivation. Motivational interviewing is a client-
centered, directive method for enhancing motivation to
change by exploring and resolving ambivalence. Brief ver-
sions of motivational interviewing that can be easily incor-
porated into the medical visit are also available.104
There is also accumulating evidence that nature of
motivation for smoking cessation is an important component
of the smoking cessation process. The intrinsiceextrinsic
model of motivation shows promise for understanding thesmoking cessation dynamics and refers to the origins of the
desire to engage in a particular behaviour. Intrinsically
motivated behaviours are generally driven by the anticipa-
tion of rewards that are internal to the person (e.g.,
improved health, self-confidence), whereas extrinsically
motivated behaviours respond to external rewards or pun-
ishments (e.g., financial gains, social approval). Although
both types of motivation may initiate behaviour change,
intrinsically motivated behaviour has been associated with
sustained changes in health behaviours, including involve-
ment in addiction treatment.105 Longitudinal studies found
that higher levels of in trinsic relative to extrinsic motivation
predict smoking cessation among self-selected, volunteer
samples of smokers seeking assistance in quitting106 and in
a general population sample of smokers.99 Thus, assessing
intrinsically motivated behaviour during consultation by
means of simple questions may be useful and can be stimu-
lated by motivational interviewing.
In practice, it is best to consider the level of the
smoker’s commitment/effort in relation to the tasks set
in his/her specific smoking cessation program. Our duty as
physicians is to keep these smokers motivated throughout
their cessation efforts by means of frequent consultations
and motivational interviewing. For those not interested in
quitting, it is important that some motivational counselling
occur during the medical visit, which is a window of
opportunity. Alternatively physicians should be encouraged
to use their regular contacts with smokers to gradually
increase their level of motivation towards a quit attempt
with the ‘‘5 R’s’’: Relevance, Risks, Rewards, Roadblocks,
and Repetition.107 Over time, this very brief encourage-
ment, in context of ongoing care, can pay off and open
the door for more productive consultation later on.
Social/familial environment
Initiation, maintenance and cessation of smoking appear to
be strongly influenced by the social environment. Smokers
are more inclined to consider a cessation attempt if they
figure out that people, whose opinion is valued, feel that
they should quit smoking and if they comprehend that
smoking is unacceptable behaviour in a number of social
situations. In a recent British study108 the strongest socioe
demographic predictors of quitting smoking in a large group
of adult smokers were, occupational social class, social sup-
port, and the number of smokers in the household. In par-
ticular, marital status and the level of support by family
members appear to be important predictor of smoking ces-
sation. These findings are similar to those published by
West et al.,109 who found that smokers whose partners ob-
jected to smoking were more likely to quit, and by Gourlay
et al.,110 who found that marital status and the presence of
smokers in the household were the strongest predictors of
quitting smoking.
Smokers are more likely to marry smokers, to smoke an
equivalent number of cigarettes as their spouse, and to quit
at the same time.111 Smokers who are married to non-
smokers or ex-smokers are more likely to quit and remain
abstinent.112 The notion that support from the spouse is
highly predictive of successful smoking cessation has been
known for a long time.113 In particular, supportive behav-
iours involving cooperative behaviours (e.g., talking the
Common predictors of smoking cessation 1189smoker out of smoking the cigarette), and reinforcement
(e.g., expressing pleasure at the smoker’s efforts to quit),
is likely to predict successful quitting whereas, negative be-
haviours (e.g., nagging the smoker and complaining about
smoking) are likely to be predictive of relapse. Thus sup-
portive behaviours were shown to be associated with suc-
cessful smoking cessation, whereas negative or critical
behaviours were related with earlier relapse.114 That family
support is an important component of effective cessation
stems from the notion that two recent systematic reviews
addressing the effectiveness of partner or social support
interventions in smoking cessation have concluded that
these interventions may be of some benefit.7,115
Several studies have shown that age is another impor-
tant social determinants of smoking cessation in the
general population. Higher success rates have been com-
monly reported for older subjects.36,116,117
The work environment is another important social de-
terminants of smoking cessation. It influence changes in
smoking in the following ways: the work environment might
influence the probability of smoking cessation; the proba-
bility of relapse following initial cessation, and the amount
of cigarettes smoked.118
Stressors in the work environment might contribute to
increased smoking ormake it harder to quit.119e123 Resources
in the work environment, e.g., decision latitude or rewards,
might strengthen the individual resources and make it easier
to reduce smoking, to quit or to avoid relapse.124
Social support can influence changes in smoking. Social
support to quit can mak e cessation easier. Conversely, the
presence of smoking co-workers can contribute to in-
creased smoking and counteract cessation.123
In these authors’ opinion it is important to consider
partner and socialefamilial support as part of an existing
smoking cessation program. However, given that physicians
may be very influential on their patients’ health decisions,
their support should not be underestimated.Final considerations
Despite the clear benefits of helping smokers to quit, there
is a growing trend in physicians’ indifference or skepticism
towards the efficacy of smoking cessation programs.8 This
may be due to a number of reasons including poor under-
standing of the natural history of cessation, the under use
of smoking cessation services, improper use of drugs for
nicotine dependence when prescribed and lack of aware-
ness of common predictors of smoking cessation.
Physicians’ expectations of successful cessation must be
reframed since most smokers are known to relapse at
some stage. For those who relapse, it is important to main-
tain contact so that relapse can be caught early enough to
facilitate rescue. Typically, multiple attempts are required
before achieving success. A better understanding of predic-
tors of smoking cessation can be useful in identifying poten-
tial quitters and likely relapsers.
Several factors are known to indicate whether a smoker
is more likely to quit and our search has identified
a number of common predictors such as late initiation of
cigarette smoking, longer duration of previous quit at-
tempts, lack of depression and anxiety, low to moderatenicotine dependence, absence of alcohol problems,
sustained level of motiv ation, being married and/or not
having any other smokers in the household and/or in the
workplace (Table 1).
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